Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer.
Clinical characteristics, treatment, and outcome of primary rectal lymphoma: a single center experience of 16 patients.
HER2 Amplification and Cetuximab Efficacy in Patients With Metastatic Colorectal Cancer Harboring Wild-type RAS and BRAF.
Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.
The role of anti-EGFR agents in patients with locoregionally advanced head and neck cancer: a meta-analysis of randomized trials.
Phase 1 Study of Preoperative Chemoradiation Therapy With Temozolomide and Capecitabine in Patients With Locally Advanced Rectal Cancer.
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
Evaluation of genetic mutations and copy number alterations in biliary tract cancer using targeted exome sequencing
Prognostic implications of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin
Prognostic implications of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma treated with first-line gemcitabine / cisplatin
# 357 Clinical Benefit of Maintenance Therapy for Patients with Advanced Biliary Tract Cancer without Progression on First-Line Gemcitabine plus Cisplatin